IFNA16 antibody (AA 101-189) (HRP)

Catalog No. ABIN717230

Product Details anti-IFNA16 Antibody (HRP)

Target: IFNA16 (Interferon, alpha 16 (IFNA16))

Binding Specificity: AA 101-189

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This IFNA16 antibody is conjugated to HRP

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificity: Possible cross-reactivity with Human IFNA4, IFNA7, IFNA10, IFNA14, IFNA17 because of sequence similarity

Cross-Reactivity: Human

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human IFNA16

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for IFNA16

Target: IFNA16 (Interferon, alpha 16 (IFNA16))

Alternative Name: IFNA16 (IFNA16 Products)

Synonyms: IFN-alphaO antibody, interferon alpha 16 antibody, interferon, alpha 16 antibody, IFNA16 antibody

Background:

Synonyms: Interferon alpha-16, IFN-alpha-16, Interferon alpha-WA, IFN-alpha-N-protein, Interferon alpha-WA, IFN-alphaO, IFN16_HUMAN, IFNA16.

Background: IFNA16 is produced by macrophages and has antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.

Gene ID: 3449

UniProt: P05015

Pathways: JAK-STAT Signaling, Hepatitis C